Optimized SMRT-UMI protocol produces highly accurate sequence datasets from diverse populations-Application to HIV-1 quasispecies.

Autor: Westfall DH; Department of Microbiology, University of Washington School of Medicine, 960 Republican Street, Seattle, WA 98195-8070, USA., Deng W; Department of Microbiology, University of Washington School of Medicine, 960 Republican Street, Seattle, WA 98195-8070, USA., Pankow A; Department of Microbiology, University of Washington School of Medicine, 960 Republican Street, Seattle, WA 98195-8070, USA., Murrell H; Department of Pathology, Division of Medical Virology, University of Cape Town and National Health Laboratory Services, Observatory, Cape Town 7925, South Africa., Chen L; Department of Microbiology, University of Washington School of Medicine, 960 Republican Street, Seattle, WA 98195-8070, USA., Zhao H; Department of Microbiology, University of Washington School of Medicine, 960 Republican Street, Seattle, WA 98195-8070, USA., Williamson C; Department of Pathology, Division of Medical Virology, University of Cape Town and National Health Laboratory Services, Observatory, Cape Town 7925, South Africa., Rolland M; US Military HIV Research Program, Walter Reed Army Institute of Research, 503 Robert Grant Avenue, Silver Spring, MD 20910, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., 6720A Rockledge Drive, Bethesda, MD 20817, USA., Murrell B; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Solnavägen 9, Stockholm 171 65, Sweden., Mullins JI; Department of Microbiology, University of Washington School of Medicine, 960 Republican Street, Seattle, WA 98195-8070, USA.; Department of Medicine, University of Washington School of Medicine, 960 Republican Street, Seattle, WA 98195-8070, USA.; Department of Global Health, University of Washington Schools of Medicine and Public Health, 960 Republican Street, Seattle, WA 98195-8070, USA.

Publikováno v: Virus evolution [Virus Evol] 2024 Mar 02; Vol. 10 (1), pp. veae019. Date of Electronic Publication: 2024 Mar 02 (Print Publication: 2024).

Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials.

Autor: Mkhize NN; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Yssel AEJ; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Kaldine H; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., van Dorsten RT; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; South African Medical Research Council Antiviral Gene Therapy Research Unit, School of Pathology, Faculty of Health Sciences University of the Witwatersrand, Johannesburg, South Africa., Woodward Davis AS; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Beaume N; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Matten D; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Lambson B; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Modise T; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Kgagudi P; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., York T; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Westfall DH; Department of Microbiology, University of Washington, Seattle, Washington, United States of America., Giorgi EE; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Korber B; Los Alamos National Laboratory, Los Alamos, New Mexico, United States of America., Anthony C; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Mapengo RE; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Bekker V; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa., Domin E; Department of Surgery, Duke University, Durham, North Carolina, United States of America., Eaton A; Department of Surgery, Duke University, Durham, North Carolina, United States of America., Deng W; Department of Microbiology, University of Washington, Seattle, Washington, United States of America., DeCamp A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Gwashu-Nyangiwe A; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Thebus R; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Ndabambi N; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Mielke D; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Department of Surgery, Duke University, Durham, North Carolina, United States of America., Mgodi N; University of Zimbabwe College of Health Sciences Clinical Trials Research Centre, Harare, Zimbabwe., Karuna S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Edupuganti S; Division of Infectious Diseases, Department of Medicine, Emory University, Decatur, Georgia, United States of America., Seaman MS; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America., Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Department of Laboratory Medicine, University of Washington, Seattle, Washington, United States of America., Cohen MS; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North-Carolina, United States of America., Hural J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Mullins JI; Department of Microbiology, University of Washington, Seattle, Washington, United States of America., Montefiori D; Department of Surgery, Duke University, Durham, North Carolina, United States of America., Moore PL; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu Natal, Durban, South Africa., Williamson C; Institute for Infectious Diseases and Molecular Medicine, Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu Natal, Durban, South Africa.; National Health Laboratory Service, Cape Town, South Africa., Morris L; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu Natal, Durban, South Africa.

Publikováno v: PLoS pathogens [PLoS Pathog] 2023 Jun 29; Vol. 19 (6), pp. e1011469. Date of Electronic Publication: 2023 Jun 29 (Print Publication: 2023).

Optimized SMRT-UMI protocol produces highly accurate sequence datasets from diverse populations - application to HIV-1 quasispecies.

Autor: Westfall DH; Department of Microbiology, University of Washington Schools of Medicine and Public Health, Seattle, WA 98195-8070 US., Deng W; Department of Microbiology, University of Washington Schools of Medicine and Public Health, Seattle, WA 98195-8070 US., Pankow A; Department of Microbiology, University of Washington Schools of Medicine and Public Health, Seattle, WA 98195-8070 US.; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Murrell H; Division of Medical Virology, Department of Pathology, University of Cape Town and National Health Laboratory Services, Cape Town, South Africa., Chen L; Department of Microbiology, University of Washington Schools of Medicine and Public Health, Seattle, WA 98195-8070 US., Zhao H; Department of Microbiology, University of Washington Schools of Medicine and Public Health, Seattle, WA 98195-8070 US., Williamson C; Division of Medical Virology, Department of Pathology, University of Cape Town and National Health Laboratory Services, Cape Town, South Africa., Rolland M; US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, 20910, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, 20817, USA., Murrell B; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 17717 Stockholm, SE., Mullins JI; Department of Microbiology, University of Washington Schools of Medicine and Public Health, Seattle, WA 98195-8070 US.; Department of Medicine, University of Washington Schools of Medicine and Public Health, Seattle, WA 98195-8070 US.; Department of Global Health, University of Washington Schools of Medicine and Public Health, Seattle, WA 98195-8070 US.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2023 Feb 24. Date of Electronic Publication: 2023 Feb 24.

Correlation between viral infections in male semen and infertility: a literature review.

Autor: Guo, Yan^1,2,3 (AUTHOR), Dong, Yunhua^2,4,5 (AUTHOR), Zheng, Runzi^2,3,4,5 (AUTHOR), Yan, Jiacong^2,4,5 (AUTHOR), Li, Weiyuan^2,4,5 (AUTHOR), Xu, Ya⁶ (AUTHOR), Yan, Xuelan^1,2 (AUTHOR), Ke, Yunmei^1,2 (AUTHOR), Li, Yantao^1,2 (AUTHOR), Xiang, Lifeng^2,4,5 (AUTHOR) xlflotus@aliyun.com

Publikováno v: Virology Journal. 7/30/2024, Vol. 21 Issue 1, p1-19. 19p.

Fitness-Balanced Escape Determines Resolution of Dynamic Founder Virus Escape Processes in HIV-1 Infection.

Autor: Sunshine JE; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Larsen BB; Department of Microbiology, University of Washington, Seattle, Washington, USA., Maust B; Department of Microbiology, University of Washington, Seattle, Washington, USA., Casey E; Department of Microbiology, University of Washington, Seattle, Washington, USA., Deng W; Department of Microbiology, University of Washington, Seattle, Washington, USA., Chen L; Department of Microbiology, University of Washington, Seattle, Washington, USA., Westfall DH; Department of Microbiology, University of Washington, Seattle, Washington, USA., Kim M; Department of Microbiology, University of Washington, Seattle, Washington, USA., Zhao H; Department of Microbiology, University of Washington, Seattle, Washington, USA., Ghorai S; Department of Microbiology, University of Washington, Seattle, Washington, USA., Lanxon-Cookson E; Department of Microbiology, University of Washington, Seattle, Washington, USA., Rolland M; U.S. Military HIV Research Program, Silver Spring, Maryland, USA, and The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA., Collier AC; Department of Medicine, University of Washington, Seattle, Washington, USA., Maenza J; Department of Medicine, University of Washington, Seattle, Washington, USA., Mullins JI; Department of Microbiology, University of Washington, Seattle, Washington, USA Department of Medicine, University of Washington, Seattle, Washington, USA Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA., Frahm N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA Department of Global Health, University of Washington, Seattle, Washington, USA nfrahm@fredhutch.org.

Publikováno v: Journal of virology [J Virol] 2015 Oct; Vol. 89 (20), pp. 10303-18. Date of Electronic Publication: 2015 Jul 29.